Figure 3.
JAK2ex13InDel and JAK2V617F use similar mechanisms of constitutive kinase activation. (A) Residues L583-A586 are located in the N-lobe of the pseudokinase domain of JAK2 (JH2) that faces the catalytically active kinase domain (JH1) (top left). L583-A586 forms the loop between the N-terminal JH2 αC and the β3 strand in JAK2WT (top right, light blue). This loop is structurally close to V617 and the JH2 αC, which is altered in the presence of the V617F mutation. Compared with the loose conformation of JH2 αC in JAK2WT (bottom right), the JH2 αC of JAK2V617F exhibits a rigid helix (bottom right). A strikingly similar conformational change in JH2 αC is observed in the JAK2ex13InDel mutant (bottom left). (B) To demonstrate that E596 is also critical for JAK2ex13InDel activity, we cultured Ba/F3 cells expressing JAK2E596R, JAK2E596R/V617F, and JAK2ex13InDel/E596R with or without IL-3. JAK2ex13InDel/E596R did not demonstrate IL-3–independent growth (n = 3).

JAK2ex13InDel and JAK2V617F use similar mechanisms of constitutive kinase activation. (A) Residues L583-A586 are located in the N-lobe of the pseudokinase domain of JAK2 (JH2) that faces the catalytically active kinase domain (JH1) (top left). L583-A586 forms the loop between the N-terminal JH2 αC and the β3 strand in JAK2WT (top right, light blue). This loop is structurally close to V617 and the JH2 αC, which is altered in the presence of the V617F mutation. Compared with the loose conformation of JH2 αC in JAK2WT (bottom right), the JH2 αC of JAK2V617F exhibits a rigid helix (bottom right). A strikingly similar conformational change in JH2 αC is observed in the JAK2ex13InDel mutant (bottom left). (B) To demonstrate that E596 is also critical for JAK2ex13InDel activity, we cultured Ba/F3 cells expressing JAK2E596R, JAK2E596R/V617F, and JAK2ex13InDel/E596R with or without IL-3. JAK2ex13InDel/E596R did not demonstrate IL-3–independent growth (n = 3).

Close Modal

or Create an Account

Close Modal
Close Modal